Brief: Sun Pharma Advanced Research Company Enters Agreement With Bioprojet To Buy Exclusive Rights For Investigational Medicinal Product SCD-044
Dec 19 (Reuters) - Sun Pharma Advanced Research Company Ltd
SPRC.NS :
* SUN PHARMA ADVANCED RESEARCH COMPANY -ENTERS LICENSING
AGREEMENT
WITH BIOPROJET TO BUY EXCLUSIVE RIGHTS FOR INVESTIGATIONAL
MEDICINAL PRODUCT, SCD-044
* SUN PHARMA ADVANCED RESEARCH COMPANY - BIOPROJET IS
ELIGIBLE TO
RECEIVE MILESTONES AND ROYALTIES ON NET SALES OF SCD-044
Source text for Eikon: ID:nBSE3qTCZM
Further company coverage: SPRC.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sun Pharma Advanced Research
See all newsAdvisory: Alert incorrectly tagged to Sun Pharma Advanced Research withdrawn
Brief: Sun Pharma Advanced Research Appoints Anil Raghavan As MD And CEO Effective August 11
Brief: Sun Pharma Advanced Research Says Ocuvex Therapeutics Gets Complete Response Letter For PDP-716 NDA
India's Sun Pharma Advanced Research jumps after swinging to Q4 profit
Brief: Sun Pharma Advanced Research March-Quarter Consol Profit 17.61 Billion Rupees